11:26 AM EDT, 08/11/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.46% to 1,966.35 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and semiconductor company Sequans Communications ( SQNS ) , which advanced 4.7% and 2.6% respectively. They were followed by telecommunications company Nokia ( NOK ) and medical device maker EDAP TMS ( FOCL ) , which increased 3.2% and 1.3% respectively.

The decliners from continental Europe were led by brewing company Anheuser-Busch InBev ( BUD ) and biopharmaceutical company DBV Technologies ( DBVT ) , which dropped 3.1% and 1% respectively. They were followed by consumer goods company Unilever ( UL ) and pharmaceutical company Novo Nordisk ( NVO ) , which were off 0.9% and 1% respectively.

The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group ( MREO ) and biotech firm Autolus Therapeutics ( AUTL ) , which surged 27% and 8% respectively. They were followed by biotech company Trinity Biotech ( TRIB ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which rose 3.5% and 1% respectively.

The decliners from the UK were led by pharmaceutical company Silence Therapeutics ( SLN ) and alcoholic beverage company Diageo ( DEO ) , which fell 2% and 1.7% respectively. They were followed by insurance firm Prudential (PUK), which was down 2.1%.